Connect with us

Science

Trump administration, Congress move to cut off transgender care for children

Published

on

Trump administration, Congress move to cut off transgender care for children

The Trump administration and House Republicans advanced measures this week to end gender-affirming care for transgender children and some young adults, drawing outrage and resistance from LGBTQ+ advocacy organizations, families with transgender kids, medical providers and some of California’s liberal leaders.

The latest efforts — which seek to ban such care nationwide, strip funding from hospitals that provide it and punish doctors and parents who perform or support it — follow earlier executive orders from President Trump and work by the Justice Department to rein in such care.

Many hospitals, including in California, have already curtailed such care or shuttered their gender-affirming care programs as a result.

Abigail Jones, a 17-year-old transgender activist from Riverside, called the moves “ridiculous” and dangerous, as such care “saves lives.”

She also called them a purely political act by Republicans intent on making transgender people into a “monster” to rally their base against, and one that is “going to backfire on them because they’re not focusing on what the people want,” such as affordability and lower healthcare costs.

Advertisement

On Wednesday, the House passed a sweeping ban on gender-affirming care for youth that was put forward by Rep. Marjorie Taylor Greene (R-Ga.), largely along party lines.

The bill — which faces a tougher road in the U.S. Senate — bars already rare gender-affirming surgeries but also more common treatments such as hormone therapies and puberty blockers for anyone under 18. It also calls for the criminal prosecution of doctors and other healthcare workers who provide such care, and for penalties for parents who facilitate or consent to it being performed on their children.

“Children are not old enough to vote, drive, or get a tattoo and they are certainly not old enough to be chemically castrated or permanently mutilated!!!” Greene posted on X.

“The tide is turning and I’m so grateful that congress is taking measurable steps to end this practice that destroyed my childhood,” posted Chloe Cole, a prominent “detransitioner” who campaigns against gender-affirming care for children, which she received and now regrets.

Queer rights groups denounced the measure as a dangerous threat to medical providers and parents, and one that mischaracterizes legitimate care backed by major U.S. medical associations. They also called it a threat to LGBTQ+ rights more broadly.

Advertisement

“Should this bill become law, doctors could face the threat of prison simply for doing their jobs and providing the care they were trained to deliver. Parents could be criminalized and even imprisoned for supporting their children and ensuring they receive prescribed medication,” said Kelley Robinson, president of the Human Rights Campaign, one of the nation’s leading LGBTQ+ rights groups.

On Thursday, the U.S. Department of Health and Human Services announced that the Centers for Medicare & Medicaid Services are proposing new rules that would ban such care by medical providers that participate in its programs — which includes nearly all U.S. hospitals. The health department said the move is “designed to ensure that the U.S. government will not be in business with organizations that intentionally or unintentionally inflict permanent harm on children.”

The department said officials will propose additional rules to prohibit Medicaid or federal Children’s Health Insurance Program funding from being used for gender-affirming care for children or for young adults under the age of 19, and that its Office of Civil Rights would be proposing a rule to exclude gender dysphoria as a covered disability.

The U.S. Food and Drug Administration, meanwhile, issued warning letters to manufacturers of certain medical devices, including breast binders, that marketing their products to transgender youth is illegal.

“Under my leadership, and answering President Trump’s call to action, the federal government will do everything in its power to stop unsafe, irreversible practices that put our children at risk,” Health and Human Services Secretary Robert F. Kennedy Jr. said in a statement. “Our children deserve better — and we are delivering on that promise.”

Advertisement

The proposed rule changes are subject to public comment, and the Human Rights Campaign and other LGBTQ+ organizations, including the Los Angeles LGBT Center, urged their supporters to voice their opposition.

Joe Hollendoner, the center’s chief executive, said the proposed changes “cruelly target transgender youth” and will “destabilize safety-net hospitals” and other critical care providers.

“Hospitals should never be forced to choose between providing lifesaving care to transgender young people and delivering critical services like cancer treatment to other patients,” Hollendoner said. “Yet this is exactly the division and harm these rules are designed to create.”

Hollendoner noted that California hospitals such as Children’s Hospital Los Angeles have already curtailed their gender-affirming services in the face of earlier threats from the Trump administration, and thousands of transgender youth have already lost access to care.

Gov. Gavin Newsom issued a statement contrasting the Trump administration’s moves with California’s new partnership with The Trevor Project, to improve training for the state’s 988 crisis and suicide hotline for vulnerable youth, including LGBTQ+ kids at disproportionately high risk of suicide and mental health issues.

Advertisement

“As the Trump administration abandons the well-being of LGBTQ youth, California is putting more resources toward providing vulnerable kids with the mental health support they deserve,” Newsom said.

California Atty. Gen. Rob Bonta’s office is already suing the Trump administration for its efforts to curtail gender-affirming care and target providers of such care in California, where it is protected and supported by state law. His office has also resisted Trump administration efforts to roll back other transgender rights, including in youth sports.

On Thursday, Bonta said the proposed rules were “the Trump Administration’s latest attempt to strip Americans of the care they need to live as their authentic selves.” He also said they are “unlawful,” and that his office will fight them.

“If the Trump Administration puts forth final rules similar to these proposals, we stand ready to use every tool in our toolbox to prevent them from ever going into effect,” Bonta said — adding that “medically necessary gender-affirming care remains protected by California law.”

Arne Johnson, a Bay Area father of a transgender child who helps run a group of similar families called Rainbow Families Action, said there has been “a lot of hate spewed” toward them in recent days, but they are focused on fighting back — and asking hospital networks to “not panic and shut down care” based on proposed rules that have not been finalized.

Advertisement

Johnson said Republicans and Trump administration officials are “weirdly obsessed” with transgender kids’ bodies, are “breaking the trust between us and our doctors,” and are putting politics in between families and their healthcare providers in dangerous ways.

He said parents of transgender kids are “used to being hurt and upset and sad and worried about their kids, and also doing everything in their power to make sure that nothing bad happens to them,” and aren’t about to stop fighting now.

But resisting such medical interference isn’t just about gender-affirming care. Next it could be over vaccines being blocked for kids, he said — which should get all parents upset and vocal.

“If our kids don’t get care, they’re coming for your kids next,” Johnson said. “Pretty soon all of us are going to be going into hospital rooms wondering whether that doctor across from us can be trusted to give our kid the best care — or if their hands are going to be tied.”

Advertisement

Science

Microplastics are everywhere — even in the labs studying them. That’s a problem for research

Published

on

Microplastics are everywhere — even in the labs studying them. That’s a problem for research

As the science of detecting microplastics matures, so too does consensus about their ubiquity. Everywhere researchers have looked to find them, there they’ve been: In human brains and lungs; in breast milk and semen; in alpine snow and deep-sea sediment; in corn plants and beer.

And that, say researchers, is the rub: Scientists are not just finding them in our livers, arteries and ovaries. They are also everywhere else: in research laboratories, pipettes, refrigerators, solvents, bottles, goggles and the very lab coats investigators are wearing to find them.

So how do we know if those particles seen under the lens of a microscope are inherent in the sample, or contamination from plastic fibers floating in the air? Or from tiny particles that sloughed off from the inside of a bottle of solvent?

Microplastics scientists are keenly aware of the problem and urgently studying it, because the credibility of the research is on the line.

Their research suddenly skyrocketed in importance with the federal government’s announcement Thursday that it will begin actively investigating the wayward, potentially toxic particles in people and drinking water.

Advertisement

“We cannot regulate what we don’t understand,” Robert F. Kennedy Jr., secretary of Health and Human Services, said at a news conference.

Nicolas Leeper, head of vascular medicine at Stanford University, said he is “absolutely” concerned that “at least some part of what has been reported [in the scientific literature] may be spurious or artifactual.”

For instance, a 2024 headline-stealing study showed a relationship between microplastics found in the arterial plaque of patients undergoing heart surgery, and a higher risk of heart attack and stroke. Several medical researchers, including Leeper, questioned the findings. They argued the authors hadn’t accounted for the introduction of microplastics during surgery.

Like most scientists in this new relatively new field, Leeper didn’t set out to study tiny, broken bits of plastic. But that study caught his attention.

“I take care of people that have atherosclerosis,” he said in an interview. “We’ve known for a while that genetics only explains about half of our lifetime risk.”

Advertisement

He now wonders if microplastics could be that X factor he’s been looking for, and is investigating the issue in his laboratory. But he’s aware the particles are everywhere.

“Think about it: Every time we work with a human bio specimen, we’re wearing plastic gloves and using plastic needles and plastic petri dishes,” he said.

Leeper is pretty sure microplastics can lead to ill health. He just wants his — and everyone’s — research to be beyond reproach.

“Given the potential public health impact of these ubiquitous … products, it is essential we know exactly what we are dealing with, how to quantify it, and how to be certain we aren’t chasing a signal that may be driven, in part, by contamination artifact,” he said.

It’s not a new concern. In fact, it’s a relatively old one.

Advertisement

Claire Gwinnett, a forensic scientist at the University of Staffordshire, in England, said she’s been fretting about microplastic contamination in her research for decades.

She’s spent most of her career inspecting dead bodies for signs of foul play. Her work requires painstaking quality control. When examining a cadaver for DNA, fibers or other chemicals and materials that could help identify a murderer, or information about a struggle, she needs complete confidence that the evidence she gathered came from the body, or perpetrator, and not from her own body, clothing or equipment.

“My entire career has been based around these teeny, tiny particulates you can’t see with the naked eye, but that I’m trying to confidently convince the courts were present on that victim in that crime scene, and not due to procedural contamination,” Gwinnett said.

About 10 years ago, she read a headline saying that researchers had found microplastic contamination in samples of deep ocean sediment — more than two miles below the surface.

“And the question for me was: Is that real? Were they actually using methods that would confidently allow them to say they actually found these microplastics at these depths, and that it wasn’t procedural contamination?”

Advertisement

She started working with environmental scientists at her university and then across the world to get them to start thinking like a forensic scientist: How can you reduce plastic in your lab or account for microplastics that are there? Are they using plastic when they could be using glass or metal? What are they wearing in the lab? Are they creating “blanks” — faux samples that go through the same preparation, in the same places, with the same researchers, using the same chemicals and materials — to account for microplastic background “noise”?

It was around this same time that Susanne Brander, director of scientific advancement efforts for the Pew Charitable Trust’s safer chemicals project, said she and other environmental scientists started asking similar questions, and establishing protocols to address contamination.

By the late 2010s, she and colleagues started replacing plastic with glass and metal, used HEPA filtration, and instituted special cleaning procedures for their equipment.

But, as often happens in science, knowledge in one research discipline doesn’t necessarily bleed into another.

There’s a silo effect, Brander said. So when people who study human health started asking questions about microplastics, they didn’t necessarily look to the water, fish and forensic folks for advice.

Advertisement

She doesn’t fault them for not reading her papers; “it’s a different research space,” she said. But it meant some of the early work on microplastics and human health didn’t use the quality controls that forensic and environmental scientists had adopted.

“Some of us have even talked about bringing these two research fields together, she said. “Maybe we should reconvene and talk about how we’ve already kind of done this.”

The human work is drawing a lot more scrutiny than the earlier work ever did.

It’s one thing to find microplastics in plants, snow and other animals. When we see it in our brains, placentas, testicles and blood — that’s different.

And as the federal government jumps into the fray, looking not only for the particles but also the potential effects on human health, the risk to the multibillion-dollar chemical and fossil fuel companies that manufacture and distribute these products grows.

Advertisement

So could scrutiny on the way we live: from food packaging, carpet manufacturing and water filtration, to medical supplies, car tires and clothing.

Plastic never goes away; it just breaks down into smaller and smaller pieces. According to the United Nations Environmental Programme, the world has produced more than 9.2 billion tons of plastic since 1950, with half of that amount produced in the last 13 years alone.

Matthew Campen, professor of pharmaceutical research at the University of New Mexico, has done some of the most well-known microplastic research on human tissue. He found it in placentas, livers, kidneys, lungs and brains.

He said the issue of contamination is real, but wonders if it’s over-hyped.

Campen was at the panel Thursday with Kennedy and Lee Zeldin, the administrator of the U.S. Environmental Protection Agency, as they announced their intention to make microplastics a research priority.

Advertisement

Although his work has also been challenged, he said that’s to be expected: The whole field of microplastic research is new, and there will be kinks that get ironed out as it matures.

“We knew that cigarettes caused cancer in the 1930s and the surgeon general didn’t say anything about it until 1966,” he said. “Ultimately, I think we’re going to move pretty fast. We’re going to invest in science in the coming years, and over the next five years, we’ll have much more confidence as to how this is getting into our bodies and what it could be doing.”

Continue Reading

Science

Next to Joshua Tree National Park, a mining company is staking its claim for rare earth minerals

Published

on

Next to Joshua Tree National Park, a mining company is staking its claim for rare earth minerals

An Australian company has launched a rare earths mining project just outside Joshua Tree National Park in critical desert tortoise habitat, an area the company’s director refers to as an “emerging heavy rare earth district.”

The company, Dateline Resources Ltd., says that historical sampling of the area in the Pinto Mountains south of Twentynine Palms found enrichment in elements key to powering electric vehicles, wind turbines and defense systems.

The United States depends heavily on China for its supply of these critical minerals, a major national security vulnerability the Trump administration has sought to address through a series of regulatory changes and financial incentives aimed at shoring up domestic production.

The desert tortoise, as seen in Music Valley in the Pinto Mountains, is listed as threatened under the Endangered Species Act due to habitat loss and predation.

(Gary Coronado / For The Times)

Advertisement

The project is in its early stages, and it’s unclear whether further testing will confirm the presence of rare earth elements across a broad enough area to warrant extracting them. The site is roughly 100 miles southwest of the nation’s only fully functional rare earths mine — Mountain Pass operated by MP Materials, in which the U.S. Department of Defense holds a 15% stake.

It’s also steps from Joshua Tree National Park, one of the nation’s most beloved desert getaways where about 3 million people visit annually. The 1,200-square-mile park and the public lands that surround it are home to sensitive plants and wildlife that environmentalists say would be harmed by a major mining project that could deplete water supplies, draw traffic and generate toxic waste.

“This is truly one of the most iconic landscapes in America,” said Chance Wilcox, California desert program manager for the National Parks Conservation Assn., as he stood atop a rocky slope within the project footprint on Friday.

Beside him, a wooden stake marked the corner of a mining claim. About 100 feet away, a metal post denoted the park’s boundary. In the valley below sat the fee booth for the east entrance.

If mining were to go ahead here, visitors would likely be able to see the activity while driving into the park, Wilcox pointed out. “It just emphasizes this company’s blatant disregard for our nation’s crown jewels,” he said.

Advertisement

Dateline did not return messages seeking comment on the project. The company also operates the Colosseum Mine in the nearby Mojave National Preserve, which the Trump administration has touted as pivotal to its efforts to develop a homegrown critical minerals supply chain.

Dateline first announced the venture — the Music Valley heavy rare earths project — late last month, saying it had acquired 57 claims totaling 1,140 acres and had also invested $1 million in Fermi Critical Minerals Inc., an American company that holds uranium and rare-earths projects in multiple western states. Dateline later broadened the footprint by staking an additional 969 claims covering 19,380 acres, a subsequent release states.

Twentynine Palms Highway looking west runs through downtown.

Twentynine Palms Highway looking west runs through downtown on Friday in Twentynine Palms, Calif.

(Gary Coronado / For The Times)

The company now holds claims over a roughly 32-square-mile area, the vast majority within the Bureau of Land Management’s jurisdiction.

Advertisement

U.S. Geological Survey geologists first identified rare earth mineralization in the Music Valley area in 1954, with sampling reporting enrichment in dysprosium, terbium, yttrium and ytterbium, Dateline Resources said in a press release. The company is now training modern exploration techniques on outcroppings of a 1.8-billion-year-old type of metamorphic rock called Pinto gneiss.

While rare earths will be the primary focus, exploration will also assess the potential for gold mining — the area is dotted with old, small-scale adits and shafts.

The project is located in what’s known as an area of critical environmental concern. The U.S. Fish and Wildlife Service has deemed the sweeping landscape to be crucial to the survival of the Mojave desert tortoise, which is endangered in California thanks to a stew of threats including development, disease, raven predation and climate change.

The land abutting the Pinto Mountains Wilderness is also home to badgers, bighorn sheep and Mojave fringe-toed lizards. Massive yuccas and barrel cacti stud its steep slopes.

A chuckwalla lizard suns itself on a rock in the Pinto Mountains.

A chuckwalla lizard suns itself on a rock in the Pinto Mountains.

(Gary Coronado/For The Times)

Advertisement

On Friday, desert iguanas and whiptails scampered across an access road, portions of which wind through the national park. A chuckwalla sunned itself on a boulder. Nearby, a desert tortoise had emerged from its burrow to munch on some grass — a rare sight that elicited a whoop of joy from Wilcox. “This is a really special place,” he said.

If the area proves to be a valuable source of heavy rare earth elements, it would be significant as the U.S. has none, said Daniel O’Connor, co-founder and chief executive of Rare Earth Exchanges, a website that covers the global rare earths market. Mountain Pass primarily produces light rare earth elements, which are typically more abundant.

“Our entire war machinery — missiles, radar, fighter jets — all need these heavy rare earths,” O’Connor said.

Still, he said, even if the U.S. were to start producing heavy rare earths, the country would likely remain reliant on China to process them — a complex, multi-stage undertaking that involves chemically separating the elements from ore. Companies controlled by the Chinese treasury currently separate and refine an estimated 90% of the world’s supply of rare earth elements, and about 90% of the specialized magnets they are used to create are also manufactured in China, he said.

Advertisement
A mural illustrating miners in the Dirty Sock Camp is painted on a wall.

A mural illustrating miners in the Dirty Sock Camp is painted on a wall in downtown Twentynine Palms, Calif.

(Gary Coronado / For The Times)

O’Connor described the Music Valley project as early-stage and speculative, pointing to a mining tradition dating back to the Wild West in which prospectors tout samples that show heavy concentrations of minerals in a bid to loosen investors’ wallets. There’s no way to know how widespread or systematic those concentrations are without technical reports disclosing a project’s mineral contents and quality, he said. Dateline does not yet appear to have released any such report, which are industry standard, he said.

Rare earths mining typically involves pulling out ore with jackhammers or dynamite and grinding it down before chemically treating it — processes that consume a lot of energy, generate toxic waste and can unleash radiation that’s often present in the ore, he said.

“It’s hard to think of a worse place for a massive industrial project than sensitive desert tortoise habitat on the very edge of Joshua Tree National Park,” wrote Brendan Cummings, conservation director for the Center for Biological Diversity, in an email.

Advertisement

A buildout of the claims could end public access to the area and permanently scar the landscape, drawing traffic and light pollution and harming springs and groundwater stores, he said. Given those potential impacts, he is skeptical that the developers could lawfully be granted the necessary federal, state, and local approvals to proceed.

Conservationists also point to Dateline’s history operating the Colosseum Mine as a source of concern, saying the company flouted National Park Service rules and damaged the surrounding landscape.

“They don’t respect public lands, national parks or the law, so there’s every reason to be deeply concerned about this proposal,” said Rep. Jared Huffman (D-San Rafael), the ranking member on the House natural resource committee who said the project “has red flags waving in every way.”

“We do need domestic and critical minerals sourced from friendly countries and responsible actors,” he added, “but it doesn’t mean we need them everywhere or at any cost.”

Advertisement
Continue Reading

Science

Hollywood rallies around former L.A. Zoo elephants Billy and Tina as they reportedly suffer in Tulsa

Published

on

Hollywood rallies around former L.A. Zoo elephants Billy and Tina as they reportedly suffer in Tulsa

Nearly a year after the Los Angeles Zoo shipped off Billy and Tina to Oklahoma, animal rights activists have kept up the call to move the elephants to a sanctuary. Recently, actor Samuel L. Jackson joined their roster of supporters.

In the dead of night last May, the pair of Asian elephants were shuttled via shipping containers to the Tulsa Zoo, where their L.A. keepers said they’d join a herd large enough for the social animals’ well-being — something the L.A. Zoo could not provide.

But animal welfare groups say the pachyderms are not better off in their new home, citing concerns about their physical and mental health.

Tina, 59, is battling a uterine infection and Billy, 40, could face invasive sperm extractions, according to Courtney Scott, veteran elephant consultant with In Defense of Animals.

The pair were already showing “very chronic stress behavior” in L.A., Scott said, such as head bobbing, swaying and pacing. In Tulsa, “that seemed to intensify.”

Advertisement

How do they know? A volunteer from the Elephant Guardians of Los Angeles visited twice and chronicled their condition with photos and videos, she said.

Scott’s group ranked the Tulsa Zoo among the 10 worst zoos for elephants last year, claiming it suffers from overcrowding and a breeding program with a checkered history.

Jackson, of “Pulp Fiction” and Marvel fame, said sanctuaries are willing to take in Tina and Billy. “Continued exploitation and denial of their freedom is making them worse, and time is running out!” Jackson said in a statement provided by In Defense of Animals.

Jackson is just the latest star to chime in. Cher, Lily Tomlin and the late Bob Barker have previously advocated for Billy, who arrived at the L.A. Zoo in 1989.

Billy roams his former habitat at the L.A. Zoo in April 2017.

Advertisement

(Richard Vogel / Associated Press)

At the Tulsa Zoo, which did not respond to requests for comment, Billy and Tina are now part of a crew that includes five other Asian elephants. The zoo’s elephant complex spans 17 acres and includes a wooded preserve not open to public viewing as well as a 36,650-square-foot barn.

This month, the zoo announced Tina was suffering from an infection and abnormal buildup of fluid in her uterus. A statement describes it as a side effect of reproductive tract disease, which she had a history of before arriving at the zoo and is common in aging female elephants.

“There are very limited options beyond antibiotics and, unfortunately, antibiotics alone will not fully resolve the infection,” the zoo said. “That reality is difficult to share, but it’s important to be transparent that this condition has the potential to become life-threatening.”

Advertisement

Tina isn’t showing signs of discomfort and remains “bright and engaged” and “greets her keepers,” according to the zoo.

Billy and Tina have lived together for more than 15 years and share a strong bond, according to the L.A. Zoo. They communicate by touching each other with their trunks, smelling each other and vocalizing.

Billy hails from a herd in Malaysia that was culled to clear land for palm and rubber plantations, according to the zoo. He arrived in L.A. at the age of 4 as part of an effort by the Malaysian government to relocate young elephants to zoos in the late 1980s.

In 2009, Tina landed at the San Diego Zoo for rehabilitation after being confiscated from a private owner. She was moved to the L.A. Zoo the following year.

For years, animal welfare advocates and some politicians tried to compel the L.A. Zoo to relocate the elephants to somewhere more spacious and which, according to them, would offer a better quality of life.

Advertisement

The L.A. Zoo, however, has long defended the care provided to its elephants and did not cite health reasons for Billy’s and Tina’s relocation in 2025.

According to an online FAQ, that decision stemmed from the death of two older herd members — Jewel and Shaunzi — who were euthanized in 2023 and 2024, respectively, for age-related health reasons. Without them, the zoo no longer met Assn. of Zoos and Aquariums standards requiring accredited zoos to have at least three Asian elephants.

The zoo said it wasn’t possible to bring in more elephants, so it made the “difficult decision” to relocate Billy and Tina, according to a statement from last year.

“The care and well-being of the animals is always a top priority and decisions impacting the animals are made at discretion of the Zoo Director — an authority granted in the Los Angeles City Charter,” the statement said. “Activist agendas and protests are rightfully not a consideration in decisions that impact animal care.”

The zoo said it spoke to sanctuaries accredited by the Assn. of Zoos and Aquariums when weighing what to do with the elephants, but elephant experts from around the country recommended Tulsa Zoo as the best fit for the pair. Criteria included space, facilities, staff expertise and herd dynamics.

Advertisement

Denise Verret, director of the L.A. Zoo, noted at an L.A. City Council budget hearing last year that the Toronto Zoo lost its accreditation in 2012 by sending its elephants to a sanctuary at the direction of the Toronto City Council.

L.A. City Councilmember Bob Blumenfield, a longtime advocate for the elephants, filed a motion seeking to pause their relocation until the City Council could review the possibility of sending them to a sanctuary. An L.A. resident filed a lawsuit over the zoo’s decision and sought to halt the elephants’ transfer. Neither effort was successful, but activists haven’t given up.

Sanctuaries in Georgia and Cambodia have agreed to take in Billy and Tina, according to Scott. Another, the Performing Animal Welfare Society in Northern California, has said it would accept Billy and, likely, Tina, she said.

“It would just be a matter of sitting down,” she said, “and figuring out the best one for the elephants.”

Advertisement
Continue Reading

Trending